Vishuo Thailand partners with BioEntist to provide Bioinnovation products and service in Thailand.
BANGKOK (August 27, 2024)
Memorandum of Understanding between Vishuo Thailand and BioEntist for business cooperation and technology enhancement
This Memorandum of Understanding is made on August 27, 2024, between Vishuo Thailand and BioEntist. Both parties have decided to sign a Memorandum of Understanding (MOU) to strengthen partnerships and advance technology, with a focus on promoting and creating visions in bioinnovation (Bio-Innovation), along with the following information:
Section 1: Cooperation objectives:
-
To create relationships, technologies, and strengthen both parties' Bio-Innovation businesses.
-
To enable consumers who purchase both parties' products and services to have access to complete Bio-Innovation products and services that cover every phase, as well as the ability to customise products and services to each customer's specific needs.
-
To co-organize Bio-Innovation training programs, conferences, and seminars with the goal of contributing to the development and advancement of Bio-Innovation research in Thailand in the near future, allowing for boundless success.
Section 2: Cooperatio Framework and Guidelines
-
Vishuo Thailand and BioEntist will work together to identify channels and opportunities for further developing business technology in order to market both parties' Bio-Innovation products and services.
-
Vishuo Thailand and BioEntist will collaborate to support pre- and post-sales services by participating in decision-making and taking various measures to provide customers who purchase both parties' products and services with comprehensive Bio-Innovation products and services that cover every phase. And can tailor products and services to the specific demands of each consumer.
-
Vishuo Thailand and BioEntist will collaborate to organise bioinnovation-related training programs, conferences, and seminars. The goal is to play a role in creating and advancing bioinnovation research in Thailand to attain infinite
Section 3: Customers that use the services offered by this collaboration will gain the following benefits
-
Customers who purchase products and services from Vishuo Thailand and BioEntist have access to comprehensive bioinnovation products and services that cover every phase and can be organised to meet each customer's specific demands.
-
Customers who buy products and services from Vishuo Thailand and BioEntist have access to bioinnovation training programs, conferences, and seminars, which promote important knowledge that benefits society as a whole and can be forwarded and expanded to related businesses to help Thailand develop its potential for sustainability.
About BioEntist, Co., Ltd.
Bioentist is a biotechnology innovation company that excels in providing cutting-edge solutions for genetic and infectious disease testing. The company specializes in establishing advanced laboratories and offers services to top organizations such as CP Group, Chulalongkorn University, Siriraj Hospital, and Mahidol University.
Bioentist is recognized for its expertise in genomics, with a particular focus on epigenetics and the emerging field of the epitranscriptome. The company's innovative approach to lab automation, especially in liquid handling, ensures precision and efficiency in high-volume testing, making it a leader in this space.
Additionally, Bioentist is actively integrating AI into biotechnology and has plans to share this knowledge through educational initiatives, such as the "Introduction to AI in Biotech" course. This reflects Bioentist's commitment to leading advancements in both biotechnology and artificial intelligence.
By offering customized laboratory setups and tailored testing solutions, Bioentist plays a pivotal role in supporting research institutions and healthcare providers, contributing to the advancement of both scientific research and practical medical applications.
For more information visit BioEntist.
For media inquiries – Sarawut Saephoo (bd@bioentist.com)
About Vishuo Biomedical (Thailand) LTD
Established in 2012 and headquartered in Singapore, Vishuo Biomedical (Thailand) LTD is one of the first providers of complete solution for Next Generation Sequencing (NGS) solutions and bioinformatics in Thailand and is now a leading provider of genomic products, data analytics, and AI-driven solutions in precision medicine. The company’s iCMDB platform – certified by ISO 13485:2003, and classified as a Class A medical device by Singapore Health Sciences Authority (HSA) – has been applied to multiple tier-one hospitals in Singapore, China, Thailand and USA. The company is committed to advancing genomic research and integrating cutting-edge technologies into the Thai healthcare ecosystem. It provides a wide range of leading-edge solutions to facilitate clinical and research projects across multiple aspects of genomics and discovery encompassing all fields of life science. Contact us for more information.
For media inquiries – Sarawut Wongphayak (sarawut@vishuo.com)
Contact us for more information: info.th@vishuo.com